is common in cancer. Many oncogenic viruses have been shown to downregulate the junctional protein connexin 43 (Cx43) and reduce GJIC. Human cytomegalovirus (HCMV) is a ubiquitous, species-specific betaherpesvirus that establishes life-long latency after primary infection. It encodes two viral gene products, immediate early (IE) proteins IE1 and IE2, which are crucial in viral replication and pathogenesis of many diseases. Emerging evidence demonstrates that HCMV DNA and proteins are highly prevalent in glioblastoma multiforme (GBM) and in other tumors, but HCMV's role in tumorigenesis remains obscure. In the present study, we examined the effects of HCMV infection on Cx43 expression and GJIC as well as the viral mechanism mediating the effects in human GBM cells and tissue samples. We found that HCMV downregulated Cx43 protein, resulting in disruption of functional GJIC as assayed by fluorescent dye transfer assay. We show that both HCMV-IE72 and IE86 mediate downregulation of Cx43 by silencing RNA targeting either IE72 or IE86 coupled with ganciclovir. This finding was further validated by transfection with expression vectors encoding IE72 or IE86, and we show that viral-mediated Cx43 depletion involved proteasomal degradation. Importantly, we also observed that the Cx43 protein levels and IE staining correlated inversely in 10 human GBM tissue specimens. Thus, HCMV regulates Cx43 expression and GJIC, which may contribute to gliomagenesis.
Introduction
Gap junctions are intercellular channels formed by multimeric assembly of connexins, which are contributed equally by the channelforming cells. Gap junctional intercellular communication (GJIC) couples neighboring cells electrically and biochemically by permitting passage of small cytosolic molecules, such as ions, nucleotides, amino acids, short peptides, second messengers and other metabolites (1) . Thus, GJIC is critical for maintaining normal cellular functions, including proliferation, differentiation and interactions with the tissue microenvironment.
A lack of GJIC is common in cancer (2, 3) . Cancerous cells escape homeostatic controls in the normal tissue microenvironment by ceasing connections and interactions with neighboring cells, enabling independent and unlimited growth, a hallmark of cancer. Poor GJIC and loss of connexin expression have been described in brain, breast, liver, lung, prostate, skin and thyroid cancers (3) . Connexins may act as tumor suppressors, a function that appears to be independent of their ability to form gap junctions (4) . Mice lacking connexin 43 (Cx43) are highly susceptible to lung cancers (5) . Knockdown of Cx43 in mouse embryonic fibroblasts results in neoplastic transformation (6) . In neuroblastoma cells, transfection with wild-type Cx43 or a C-terminal domain of Cx43 that cannot form channels reduces cellular proliferation and tumor growth (7) . Similarly, exogenous expression of Cx43 reverses the malignant phenotype of glioblastoma multiforme (GBM) cell lines, including glioma stem cells (8, 9) .
Cx43 interacts with and modulates the expression of many genes involved in cell cycle control and tumorigenesis (10, 11) . Chemicals, oncogenes, and growth factors that initiate tumorigenesis or facilitate tumor progression can also suppress connexin expression and inhibit GJIC (12) . In contrast, retinoids and carotenoids protect against cancer by upregulating connexin and GJIC (13) . Furthermore, many oncogenic viruses such as human papillomavirus, simian virus 40 and avian sarcoma virus downregulate Cx43 and reduce GJIC (14) (15) (16) .
Human cytomegalovirus (HCMV) is a double-stranded DNA virus that belongs to the family Herpesviridae and subfamily Betaherpesvirinae. It is a ubiquitous but species-specific betaherpesvirus that remains latent or persistent in host cells upon primary infection. Its seroprevalence varies from 40 to 100% depending on age, socioeconomic status and geographical locations (17) . HCMV is known for its opportunistic infection in immunocompromised individuals such as in acquired immunodeficiency syndrome patients, organ and stem cell transplant patients and it is the main etiological agent responsible for congenital diseases in newborn babies (18) . HCMV can be transmitted through saliva, urine, breast milk, perinatal, blood and possibly via prolonged close contact (18) . Replication of HCMV occurs in the nucleus of the infected cells and is regulated in a stepwise manner with the first expression of immediate early (IE) genes, which are regulatory genes controlling early and late genes expression in cells permissive for the infection (18) . The IE1-p72 and IE2-p86 encoded by the IE gene 1 and 2, respectively, are the most extensively studied as both gene products play a crucial role in viral replication and have been implied in the pathogenesis of many diseases (19) .
HCMV's DNA and proteins have been identified in various solid tumors, such as malignant gliomas, medulloblastomas, neuroblastomas and cancers of the colon, breast, lung and prostate (20) (21) (22) (23) (24) . In >90% of these tumors, HCMV proteins are highly expressed in tumor tissue but are absent in healthy surrounding tissues. Despite the association between HCMV and cancer, an oncogenic role for HCMV has not been established. However, HCMV promotes neoplastic transformation (25) (26) (27) , induces mucoepidermoid proliferation by activating oncogenic signaling pathways and is associated with carcinoma of salivary glands (28) .
HCMV efficiently downregulates Cx43 expression in fibroblasts (29) , but its effects in tumor cells as well as the viral mechanism mediating these effects are not known. We therefore investigated the effects of HCMV on Cx43 expression in GBM cells and human GBM samples as well as in fibroblasts. Our findings suggest a role for HCMV-regulated Cx43 in gliomagenesis.
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authentication was provided with the purchase. All cell lines have been used within 6 months after receipt. U373MG cells were maintained in RPMI-1640 medium, U251MG and MRC-5 in minimal essential medium (Life Technologies) supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were infected with HCMV strain VR1814 (kindly provided by G.Gerna, University of Pavia, Italy). The virus was either prepared from supernatants of infected human umbilical vein endothelial cells grown in EBM-2 medium (Clonetics; Cambrex) or subjected to ultracentrifugation and redissolved in 0.1 M sucrose phosphate buffer, frozen and stored at -80°C until use. Viral titers were determined with plaque assay as described before (30) . Cells were grown to 70% confluence and infected with VR1814 at different multiplicity of infection (MOIs). Cells were treated with ganciclovir (GCV) (Hoffmann La Roche Ltd, Basel, Switzerland) at 2.5 mM for 3 days. For Cx43 degradation analysis, the proteasome inhibitor (PI) MG132 (474791; Calbiochem) was used at a concentration of 10 μM for 1 day.
Establishment and expansion of primary GBM cells
Resected fresh GBM tumor tissue specimens from patients at Karolinska University Hospital, Sweden (ethical permission 2008/628-31/2 from Stockholm Regional Ethical Committee) were cut into small pieces and dissociated enzymatically (0.5% trypsin-ethylenediaminetetraacetic acid) and mechanically into single cell suspensions. Blood cells were lysed in NH 4 Cl lysis buffer. Isolated cells were expanded in DMEM/F12 (1:1) medium (Invitrogen) supplemented with 7% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. The expanded cells were characterized as GBM cells, number coded and cells of 1-3 passage were used for experiments. GBM 30 and GBM 48 were randomly selected to be used in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (see below).
Immunofluorescence staining
Cells were cultured on 8-well glass cell culture slides, fixed in ice-cold acetone-methanol (1:1) for 10 min and blocked in serum-free protein blocking solution (DakoCytomation) for 30 min. The cells were incubated with primary antibodies overnight and with fluorochrome-conjugated secondary antibodies for 1 h. The slides were mounted with fluorescent mounting medium containing the nuclear counterstain 4′,6-diamidino-2-phenylindole (DAPI) (DakoCytomation; S3023). Bound antibodies were visualized and photomicrographs were taken with a confocal microscope (Leica TCS SP5) equipped with Leica Application Suite Advanced Fluorescence software (Leica Microsystems, Wetzlar, Germany). The following antibodies were used: mouse monoclonal anti-HCMV IE proteins (11-003, Argene; 1:100), rabbit polyclonal anti-Cx43 (C6219, Sigma; 1:1000), Alexa Fluor-488-conjugated goat anti-rabbit (Molecular Probes; 1:500) and Alexa Fluor-594-conjugated goat anti-mouse (Molecular Probes; 1:500).
Protein extraction and western blot
Proteins were extracted in radioimmunoprecipitation assay protein extraction buffer supplemented with Complete Protease Inhibitor Cocktail (Roche) and phosphatase inhibitor cocktail (Sigma). Protein samples were prepared in Novex Sample Buffer (Invitrogen) containing 0.1 M dithiothreitol or Laemmli buffer containing 5% β-mercaptoethanol, boiled, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 4-12% gels and transferred onto polyvinylidene difluoride membrane. The membrane was blocked with 5% non-fat dry milk dissolved in Tris-buffered saline supplemented with 0.05% Tween 20 and probed with mouse monoclonal anti-HCMV IE proteins (11-003; Argene or MAB810R; Millipore, both at 1:1000), rabbit polyclonal anti-Cx43 (C6219, Sigma; 1:8000) or mouse monoclonal anti-β-actin (NB600-501, 1:3000 or sc-47778, 1:1000). After washings in Tris-buffered saline with 0.05% Tween 20, the membrane was incubated with anti-mouse (1:3000) or anti-rabbit immunoglobulin G (IgG) (1:3000) coupled to horseradish peroxidase. Equal loading of proteins was verified by stripping and reprobing the membranes with mouse monoclonal antibody against β-actin. Bound antibodies were detected with the enhanced chemiluminescence-Plus chemiluminescence kit (Amersham). For quantification, films were scanned and images were analyzed with Image J software (National Institutes of Health; http://imagej. nih.gov/ij/, 1997-2011).
Quantitative TaqMan PCR Cells were collected and homogenized with QIAshredder (Qiagen), and total RNA was extracted with the RNeasy RNA kit (Qiagen) according to the manufacturer's protocol. Complementary DNA was synthesized from equal amounts of RNA with the SuperScript III First-Strand Synthesis System (Invitrogen, Life Technologies) and Oligo(dT)20. The complementary DNA was then used for quantitative PCR for HCMV IE gene (forward primer:
TGACGAGGGCCCTTCCT; reverse primer: CCTTGGTCACGGGTGTCT; probe: FAM-AAGGTGCCACGGCCCG-NFQ) and Cx43 (Hs00748445_s1) with TaqMan gene expression assays (Applied Biosystems). Gene expression values were normalized to either β-actin (Hs99999903_m1) or β 2 -microglobulin (Hs00187842_m1). Each experiment was performed in duplicate and repeated three times.
Transfection and siRNA knockdown of IE72 and IE86
Plasmids containing IE72 (pGFP-72) or IE86 (pGFP-86) were a kind gift from Prof. J.A.Nelson (Oregon Health & Sciences University). Cells were transfected using lipofectamine 2000 with either pGFP-72 or pGFP-86 diluted in Opti-MEM (Invitrogen), according to the manufacturer's protocol. Four to six hours later, the transfection medium was replaced with growth medium. For knockdown, previously described IE72 and IE86 small interfering RNAs (siRNAs) sequences (Dharmacon, Lafayette, CO) and protocol were used (31) . In brief, 90% confluent cells in 6-well plates were transfected with siRNAs for 24 h, infected with HCMV (MOI of 5) and harvested for protein analysis after 16-18 h of infection.
Functional GJIC assay
Donor and recipient cells were grown as identical parallel cultures on 6-well plates and infected with HCMV (MOI of 5) for 3 days. Donor cells were then incubated with 10 μM DiI (Molecular Probes) and 5 μM calcein AM (Molecular Probes; C-3099) in serum-free medium for 20 min at 37°C. The double-labeled cells were rinsed with phosphate-buffered saline, trypsinized, counted and added to a subconfluent monolayer of unlabeled cells at a ratio of 1:100 (labeled:unlabeled). Transfer of gap junction-permeable calcein from the double-labeled donor cell to recipient cells was monitored after 3 h (MRC-5 cells) and 6 h (GBM cell lines). Calcein transfer was assessed in several microscopic fields and was visually counted only when there was at least one calcein-recipient cell and when the donor was a single cell that was enough away from another single donor cell so that there was no overlapping calcein transfer. Each experiment (three replicates) was repeated three times. Images were taken with an Olympus BX50WI microscope and a digital camera (Nikon D7000).
MTT Cell proliferation assay
Cell proliferation was assessed by the Roche MTT cell proliferation assay using a 96-well plate format according to the manufacturer's instruction. Approximately 5000 viable cells per well were seeded in eight replicate wells, infected with ultracentrifuged-purified HCMV (MOI of 5) and assayed for proliferation at 1, 3 or 5 days postinfection. Mock controls were treated with same amount of sucrose phosphate buffer or growth medium.
Cell invasion assay
Cell invasion was performed using BD Biocoat Growth Factor Reduced Matrigel Invasion Chamber (BD, Bedford, MA) with 8.0 μm filter membranes according to the manufacturer's protocol. Briefly, cells were grown and infected with ultracentrifuged-purified HCMV (MOI of 5) in a 6-well plate for 5 days prior to plated onto the prehydrated chamber inserts with 5 × 10 4 U373MG cells resuspended in 500 μl of DMEM/F12 medium containing 0.1% FBS. Thereafter, 750 μl of DMEM/F12 medium containing 10% FBS was added onto the wells as chemoattractant. After 24 h, the upper membrane surface was cleaned with a cotton swab. Cells on the lower membrane surface were fixed in ice-cold acetone-methanol (1:1) and stained with DAPI. Five fields of cells were randomly counted in each well under the confocal microscope at ×10 magnification.
Immunohistochemistry of GBM samples
Paraffin-embedded tissue sections (6 μm thick) were obtained from 10 GBM patients at Karolinska University Hospital, Stockholm, Sweden. Tissue collection was approved by the Stockholm Regional Ethical Committee (ethical permission no. 2008/628-31/2). The sections were stained for HCMV, as described previously (20, 24, 32) . Briefly, sections were deparaffinized, rehydrated, postfixed and epitope was retrieved using pepsin (BioGenex). 3% H 2 O 2 (Sigma-Aldrich), avidin/biotin blocking kit (Dako), Fc receptor blocker and Background Buster (Innovex Biosciences) were applied before incubation with primary and secondary antibodies. Antibodies in singly stained sections were visualized with streptavidin-conjugated horseradish peroxidase and diaminobenzidine (Innovex Biosciences). For double staining, the Wrap Red Chromagen Kit (Biocare) was used for Cx43. The following primary antibodies were used: mouse monoclonal anti-HCMV IE proteins IgG2a (MAB810, Chemicon; 1:100) and rabbit polyclonal antiCx43 (C6219, Sigma; 1:4000). Mouse monoclonal antibody (IgG2a) against smooth muscle cell α-actin (BioGenex; 1:100) and rabbit IgG (NC495H; Biocare Medical) served as staining controls for HCMV IE proteins and Cx43, respectively. 
CMV disrupts gap junction communication in gliomas

Statistical analysis An unpaired Student's t-test assuming equal variance was used for statistical comparison. Statistical tests and P values were two sided. P values that were <0.05 were considered to connote statistical significance. (Figure 1a) . The reduction increased with higher viral doses as evidenced at 3 days after infection (Figure 1a) . In uninfected cells, Cx43 was localized in the cell membrane and around the nucleus, as shown by immunofluorescence staining (Figure 1b) . In HCMV-infected cells, Cx43 staining was substantially reduced (Figure 1b) , confirming the western blot results. Cx43 levels were also reduced in HCMV IE proteins-negative cells in infected cultures (Figure 1b) . However, even at a higher dose or longer durations of infection, HCMV had no effect on Cx43 messenger RNA (mRNA) levels (Figure 1c and d) .
Results
HCMV downregulates Cx43 protein expression without affecting its transcription in GBM cell lines
GBM cell line U373MG was infected with HCMV clinical strain VR1814 at a MOI of 0.1, 1 and 10, and cell pellets were collected at 1, 3 or 7 days after infection. At 1 day after infection, the Cx43 protein level was 50% lower in HCMV-infected cells than in mock-infected or uninfected cells, as shown by western blot
HCMV downregulates Cx43 protein and mRNA levels in normal fi broblasts
In human fibroblasts, Cx43 was shown to be downregulated by infection with the HCMV laboratory strains AD169 and Toledo (29) . To assess the effects of HCMV clinical strain VR1814 on Cx43 levels in fibroblasts, we infected MRC-5 fibroblasts at a similar MOI. As in the GBM cell lines, Cx43 protein levels were reduced in a doseand time-dependent fashion (Figure 2a) . At 3 days after infection, the Cx43 protein level was 95% lower in HCMV-infected cells (MOI of 10) than in mock-infected controls (Figure 2a) . By immunofluorescence staining, the membranous deposition of Cx43 in uninfected MRC-5 cells was almost completely absent in HCMV-infected cells; Cx43 was also decreased in uninfected MRC-5 cells in infected cultures (Figure 2b ), as in U373MG cultures (Figure 1b) . HCMV drastically reduced Cx43 mRNA levels in a dose-and time-dependent manner in infected MRC-5 cells (Figure 2c and d) , in contrast to its lack of effect in infected GBM cells (Figure 1c and d) .
HCMV disrupts functional GJIC
The effects of HCMV on the function of GJIC in U373MG cells and MRC-5 fibroblasts were evaluated by cell-to-cell transfer of calcein (a gap junction-permeable dye) and DiI (which cannot be transferred across a gap junction). When cells labeled with both calcein and DiI were seeded on a monolayer of unlabeled cells, calcein transfer was significantly lower in HCMV-infected cultures than in uninfected cultures. On average, an infected donor U373MG cell transferred calcein to <5 infected recipient U373MG cells, whereas an uninfected U373MG cell transferred calcein to ~20 recipient cells (Figure 3a and  b) . The GJIC-disrupting effect of HCMV was similar in U373MG cells and normal fibroblasts; dye transfer between infected cells was reduced by 75% compared with the transfer between uninfected cells. However, fibroblasts exhibited a higher capacity to transfer calcein. On average, a single uninfected MRC-5 fibroblast transferred calcein to >40 uninfected cells but to <10 infected cells (Figure 3c and d) . Many infected calcein donor cells did not couple at all with neighboring recipient cells, as no calcein transfer was observed in some cells. Thus, HCMV-infected cells cannot establish functional GJIC.
HCMV IE proteins predominantly participate in Cx43 downregulation
Next, we investigated whether IE or late HCMV proteins affect Cx43 expression. During HCMV infection, U373MG cells were treated with 2.5 mM GCV to prevent expression of late proteins but not IE proteins. GCV did not affect HCMV's ability to decrease Cx43 expression levels (Figure 4a 
HCMV downregulates Cx43 through a proteasome-dependent mechanism
Cx43 is regulated by proteasomal degradation. To further explore the mechanism by which HCMV-IE72 or IE86 decreases Cx43 protein level without affecting its transcription in GBM cells, we infected U373MG and U251MG GBM cells with HCMV at an MOI of 5 and simultaneously treated the cells for 24 h with the PI MG132 (10 μM). This treatment prevented the effects of HCMV on Cx43 expression, and the Cx43 levels were similar to those in uninfected U373MG and U251MG cells (Figure 5a ). MG132 also prevented loss of Cx43 from cell membranes in both GBM cell lines, as shown by immunofluorescence staining and confocal microscopy (Figure 5b and c) . In some infected cells, the Cx43 level was even higher after drug treatment (Figure 5b , inset in lower panel). Since MG132 inhibits protein degradation via the proteasome pathway, these findings strongly suggest that HCMV targets Cx43 for proteasomal degradation.
Treatment with MG132 slightly increased Cx43 protein levels in both uninfected GBM cell lines (Figure 5a) , which was not unexpected as Cx43 has a high turnover through degradation. Cx43 was localized at the cellular membrane of MG132-treated U373MG cells (Figure 5b , inset in upper panel) but was mainly perinuclear in MG132-treated U251MG cells (Figure 5c, inset in upper panel) . Interestingly, MG132 reduced both IE72 and IE86 protein levels in both GBM cell lines, and IE86 was almost completely absent (Figure 5a, Supplementary Figure 2 , available at Carcinogenesis Online). Thus, it is also possible that MG132 upregulated Cx43 expression by inhibiting HCMV IE proteins expression and preventing Cx43 degradation. This observation further strengthens our finding that HCMV IE proteins decrease Cx43 expression.
HCMV infection is not lytic in GBM cells and renders GBM cells more invasive
We next questioned how HCMV infection impacts on gliomagenesis by both proliferation and invasion assays in GBM cells. We found that HCMV infection dose dependently reduced number of viable cells per se (Figure 6a) . Interestingly, the proliferation of the highly infected cells (MOI of 10) increased over the time course albeit not in the same pace as the uninfected cells (Figure 6a) . The similar findings hold true for two examined primary GBM cells (Figure 6a) . By invasion assay, we observed that HCMV-infected cells were more invasive compared with uninfected cells (Figure 6b) . Hence, HCMV infection is not lytic in GBM cells and renders GBM cells more invasive. 
HCMV IE proteins and Cx43 expression inversely correlated in Human GBM
Discussion
This study shows that HCMV decreases the expression of Cx43 mRNA and protein in fibroblasts and reduces the level of Cx43 protein in GBM cells without affecting its transcription. The decrease in Cx43 protein levels in HCMV-infected cells may result from enhanced degradation of Cx43 via the proteasome pathway. Cx43 was downregulated by HCMV-IE72 and IE86 but not by late proteins. In human GBM tissue specimens, HCMV infection correlated inversely with Cx43 expression. Our findings imply an important role for HCMV in Cx43 degradation and disruption of GJIC and reveal yet another viral mechanism that may modulate gliomagenesis.
It is not known whether HCMV expression in tumors is oncogenic, confers oncomodulatory functions or is merely an epiphenomenon. After primary infection, HCMV remains dormant in myeloid cell lineage throughout the life of the host and may be reactivated by immune suppression or inflammation, resulting in differentiation of latently infected cells into macrophages or dendritic cells (33, 34) . Many HCMV proteins that affect host cellular and immunological functions to ensure viral persistence may also contribute to tumorigenesis. Certain HCMV proteins clearly have both oncogenic and oncomodulatory functions. The HCMV chemokine receptor homolog US28 induces expression of nuclear factor-κB and cyclooxygenase-2, phosphorylation of STAT3 and production of interleukin-6 and vascular endothelial growth factor (35, 36) . Moreover, HCMV US28 and its ligand CCL-5 may contribute to gliomagenesis by inducing an invasive and angiogenic phenotype (37) . Transgenic mice expressing US28 in the intestine develop adenomas and adenocarcinomas through an effect on glycogen synthase 3β and β-catenin (38) . In line with these findings, we showed that HCMV infection is not lytic in GBM cells and renders GBM cells more invasive. Oncogenic viruses commonly induce telomerase activity. We showed that the HCMV-IE72 induces high levels of telomerase activity by interacting with the human telomerase reverse transcriptase promoter. Interestingly, only HCMV IE proteins-positive GBM cells in human surgical sections had increased expression of human telomerase reverse transcriptase (32) . Other HCMV proteins block cellular differentiation, apoptosis and DNA repair mechanisms, induce chromosomal instability and mutagenesis, promote angiogenesis and cellular migration and interfere with expression of oncogenes and proto-oncogenes (39-41).
HCMV's effect on Cx43 is an additional strategy by which the virus likely influences tumorigenesis. The antiviral drug GCV did not prevent downregulation of Cx43 in infected cells, indicating that HCMV late proteins are not involved in regulating Cx43 expression (Figure 4a) . In GBM cells, IE72 and IE86 were the major Cx43 regulatory HCMV proteins. Expression of either protein caused a near complete loss of Cx43 (Figure 4b ). This loss was prevented by siRNAinduced knockdown of IE72 or IE86 in HCMV-infected GBM cells (Figure 4c Since HCMV IE proteins regulate transcription, we expected that its effect on Cx43 transcription in GBM cells would resemble that in fibroblasts. That expectation was not fulfilled. HCMV reduced Cx43 protein levels and inhibited GJIC in GBM cells, but had no effect on mRNA levels. Precisely, how Cx43 gene expression in GBM cells escapes regulation by HCMV IE proteins are not known. In a study of malignant gliomas, Cx43 protein levels were low, as expected, but Cx43 mRNA levels were persistently very high; the authors suggested posttranscriptional regulation as the mechanism for the loss of Cx43 protein (42) . Using the PI MG132, which blocks the chymotrypsinlike activity of proteasome and has been used to investigate Cx43 degradation (43), we showed that MG132 prevents the HCMV-mediated downregulation of Cx43 in both cell lines ( Figure 5 ). These results suggest that HCMV IE proteins degrade Cx43 via the proteasome pathway. On the other hand, it has been shown that MG132 is capable of reducing HCMV IE proteins expression through a direct effect on its major IE promoter (44) . Since our data showed that MG132 not only induced Cx43 protein level in uninfected GBM cells but also decreased HCMV IE protein levels, especially IE86 in infected GBM cells. Thus, we conclude that MG132-induced increase in Cx43 level in infected GBM cells primarily reflects prevention of proteasomal degradation but not due to decreased IE protein expression. However, our findings that the MG132 also decreased HCMV IE proteins presumably had an additive effect on the upregulation of Cx43 in the infected cells, further support the evidence that IE proteins are responsible for HCMV's ability to affect Cx43 protein expression.
GJIC-dependent and GJIC-independent roles for decreased Cx43 level have been described in tumorigenesis (4). We found that HCMV infection significantly disrupted GJIC in both cell types (Figure 3 ), many infected cells failed to form GJIC with neighboring cells. These findings suggest that a Cx43-mediated role involving HCMV in tumorigenesis is GJIC dependent, although it does not exclude a simultaneous GJICindependent role for the HCMV-induced decrease in Cx43 expression.
In human GBM tissue samples, Cx43 expression was absent mainly in HCMV IE proteins-positive cancer cells, as shown by immunohistochemical analysis. This finding further implies that HCMV affects tumorigenesis by downregulating Cx43 in vivo.
Cx43 is downregulated by another oncogenic virus, human papillomavirus (14) . Since this effect appeared early in the dysplastic stage of cervical cancer development (45) , loss of Cx43 expression may be an early event in malignant transformation. Taken together, our findings suggest that HCMV-IE72 and IE86 mediate proteasomal degradation of Cx43 resulting in disruption of GJIC in glioblastomas and this gap junction-modulating role of HCMV may take place in an earlier stage of the tumor development. HCMV is consistently detected in various solid tumors and may have a similar Cx43-mediated tumorigenic role in many different cancers. Supplementary Figures 1-3 
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